Your position:m.limatoxi.com >> EN >> EN >> Formulation >> The battle between Pfizer Gilead over COVID-19 drugs will continue >> article
 
The battle between Pfizer Gilead over COVID-19 drugs will continue
Editor:xuezhe    Clicks:0    Date:2022-11-4 16:41:52
Keyword: COVID-19 drugs
Healthoo Information:
The battle between Pfizer Gilead over COVID-19 drugs will continue
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • Market Report of Monoclonal Antibody Drugs in China (2022)
  • Innovative drugs - Medium long-term growth still has more room for imp...
  • Chinas innovative drugs entering the global market is the future trend...
  • In the first half of 2022, Chongqing exported about 880 million yuan o...
  • 2022H1: Top 10 Best-Selling Drugs in the World
  • Pfizer to Increase Production Capacity of Coronavirus Oral Drugs, Inve...
  • Pfizer to Increase Production Capacity of COVID-19 Oral Drugs, Invest ...
  • 4 Innovative Drugs are Expected to be Approved by the FDA in June
  • Anke Bio Afana Collaborate on mRNA Vaccines for Mutant Strains Such as...
  • Anke Bio Afana Collaborate on mRNA Vaccines for Mutant Strains Such as...
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map